Pharmacy Benefit Manager Accountability Study Act of 2019
USA116th CongressHR-3223| House
| Updated: 6/13/2019
Roger Marshall
Republican Representative
Kansas
Cosponsors (4)
Health Subcommittee, Energy and Commerce Committee
- Introduced
- In Committee
- On Floor
- Passed Chamber
- Enacted
Pharmacy Benefit Manager Accountability Study Act of 2019 This bill requires the Government Accountability Office to study the role of pharmacy benefit managers (PBMs) with respect to federally facilitated exchanges, including the role of PBMs in pharmaceutical supply chains, the competition among PBMs, and the use of rebates and fees by PBMs in such exchanges.
View Full TextSuggested Questions
Get AI-generated questions to help you understand this bill better
Timeline
Introduced in House
Referred to the House Committee on Energy and Commerce.
Referred to the Subcommittee on Health.
Health
Competition and antitrustCongressional oversightConsumer affairsDrug therapyGovernment studies and investigationsHealth care costs and insuranceHealth care coverage and accessInflation and pricesPrescription drugsUser charges and fees
Pharmacy Benefit Manager Accountability Study Act of 2019
USA116th CongressHR-3223| House
| Updated: 6/13/2019
Pharmacy Benefit Manager Accountability Study Act of 2019 This bill requires the Government Accountability Office to study the role of pharmacy benefit managers (PBMs) with respect to federally facilitated exchanges, including the role of PBMs in pharmaceutical supply chains, the competition among PBMs, and the use of rebates and fees by PBMs in such exchanges.
View Full TextSuggested Questions
Get AI-generated questions to help you understand this bill better
Timeline
Introduced in House
Referred to the House Committee on Energy and Commerce.
Referred to the Subcommittee on Health.
Roger Marshall
Republican Representative
Kansas
Cosponsors (4)
Health Subcommittee, Energy and Commerce Committee
Health
- Introduced
- In Committee
- On Floor
- Passed Chamber
- Enacted
Competition and antitrustCongressional oversightConsumer affairsDrug therapyGovernment studies and investigationsHealth care costs and insuranceHealth care coverage and accessInflation and pricesPrescription drugsUser charges and fees